RESCINDED
July 31, 2024
Office of Research on Women's Health (ORWH)
The purpose of this notice is to inform applicants of a change to the Key Dates for RFA-OD-22-014, "Specialized Centers of Research Excellence (SCORE) on Sex Differences (U54 Clinical Trial Optional)". The Notice of Funding Opportunity (NOFO) has been extended to add a new application due date of January 9, 2025, and a new expiration date of January 10, 2025.
The additional receipt has been added, January 9, 2025, for new, renewal, and resubmission applications.The changes below are in bold italics.
The Notice of Funding Opportunity currently reads as:
Application Due Date(s) September 30, 2022 and August 15, 2024. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Application Due Date(s) Not Applicable
Scientific Merit Review October/November 2022 and October/November 2024
Advisory Council Review May/June 2023 and January/February 2025
Earliest Start Date July 2023 and May 2025
Expiration Date August 16, 2024
Application Due Date(s) September 30, 2022; August 15, 2024; March 13, 2025. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Application Due Date(s) Not Applicable
Scientific Merit Review October/November 2022; October/November 2024; June/July 2025
Advisory Council Review May/June 2023; January/February 2025; October 2025
Earliest Start Date July 2023; May 2025; February 2026
Expiration Date March 14, 2025
All other aspects of the NOFO (RFA-OD-22-014) remain the same.
Please direct all inquiries to:
Rajeev K. Agarwal, Ph.D.
Office of Research on Women's Health (ORWH)
Telephone: 301-451-7058
Email: [email protected]